Clover Health Investments, Corp.: CEO Wai Conrad sold 23,627 shares

What happened Wai Conrad, CEO (Counterpart Health), sold 23,627 shares of Class A common stock in an open market or private sale on Oct 15, 2026, at a weighted average price of $4.68 per share, for total proceeds of $110,574.

Key details

• Transaction date and price: Oct 15, 2026; weighted average price $4.68; sales occurred at prices ranging from $4.67 to $4.68 (footnote F2).
• Transaction type and code: sale (S); described as an open market or private sale.
• Shares owned after the transaction: not reported in this Form 4.
• Relevant footnotes from the filing:
  • F1: The shares sold were required to be sold to cover tax withholding in connection with the vesting of 6.25% of RSUs originally granted Oct 15, 2024; remaining RSUs vest quarterly in equal installments of 6.25% with final vesting on Oct 15, 2028, subject to continued service. The sales were mandated by the issuer’s sell-to-cover election and are not discretionary trades by the reporting person.
  • F2: Price is a weighted average; shares sold at prices ranging from $4.67 to $4.68 and the reporting person will provide finer detail on request.
  • F3: Some shares are held in trust for the benefit of the reporting person’s family, of which the reporting person is a co-trustee.
• Filing date and timeliness: Form filed Oct 19, 2026 reporting a transaction on Oct 15, 2026; the filing does not indicate that it was filed late.

Why it may matter The filing says the sale was a sell-to-cover to satisfy tax withholding obligations tied to RSU vesting rather than a discretionary sale. The filing does not show why the insider traded or why the company acted.